Technical Analysis for EPRX - Eupraxia Pharmaceuticals Inc

Grade Last Price % Change Price Change
F 1.99 2.05% 0.040
EPRX closed up 2.05 percent on Friday, December 3, 2021, on 61 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical EPRX trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 2.05%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.05%
Lower Bollinger Band Walk Weakness 2.05%
Stochastic Reached Oversold Weakness 2.05%
Outside Day Range Expansion 2.05%
Lower Bollinger Band Touch Weakness 2.05%
Oversold Stochastic Weakness 2.05%
Older End-of-Day Signals for EPRX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Eupraxia Pharmaceuticals Inc Description

Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidate, EP-104IAR, that is in a Phase II clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis, as well as under development for treatment of canine and equine osteoarthritis. Its products in development also include EP-201, a product candidate for prophylaxis of post-surgical infections; and EP-105, an extended-release product candidate for the local delivery of anesthetics to treat post-surgical pain. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012. Eupraxia Pharmaceuticals Inc. was founded in 2012 and is headquartered in Victoria, Canada.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Pain Biotechnology Life Sciences Arthritis Osteoarthritis Skeletal Disorders

Is EPRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 7.19
52 Week Low 1.9
Average Volume 19,036
200-Day Moving Average 0.000
50-Day Moving Average 2.352
20-Day Moving Average 2.083
10-Day Moving Average 2.029
Average True Range 0.123
ADX 12.34
+DI 23.046
-DI 22.565
Chandelier Exit (Long, 3 ATRs) 2.030
Chandelier Exit (Short, 3 ATRs) 2.270
Upper Bollinger Bands 2.247
Lower Bollinger Band 1.919
Percent B (%b) 0.22
BandWidth 15.718
MACD Line -0.102
MACD Signal Line -0.109
MACD Histogram 0.0064
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.125
Resistance 3 (R3) 2.110 2.050 2.103
Resistance 2 (R2) 2.050 2.016 2.058 2.095
Resistance 1 (R1) 2.020 1.994 2.035 2.035 2.087
Pivot Point 1.960 1.960 1.968 1.968 1.960
Support 1 (S1) 1.930 1.926 1.945 1.945 1.893
Support 2 (S2) 1.870 1.904 1.878 1.885
Support 3 (S3) 1.840 1.870 1.878
Support 4 (S4) 1.855